Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.

Wang SJ, Earle C, Wong G, Bourguignon LY.

Head Neck. 2013 Apr;35(4):511-20. doi: 10.1002/hed.22991. Epub 2012 Mar 31.

PMID:
22473523
2.
4.

Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.

Bourguignon LY, Earle C, Wong G, Spevak CC, Krueger K.

Oncogene. 2012 Jan 12;31(2):149-60. doi: 10.1038/onc.2011.222. Epub 2011 Jun 20.

5.

Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.

Wang SJ, Bourguignon LY.

Am J Pathol. 2011 Mar;178(3):956-63. doi: 10.1016/j.ajpath.2010.11.077. Review.

6.

CD44 variant isoforms in head and neck squamous cell carcinoma progression.

Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY.

Laryngoscope. 2009 Aug;119(8):1518-30. doi: 10.1002/lary.20506.

7.

Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.

Dong C, Ye DX, Zhang WB, Pan HY, Zhang ZY, Zhang L.

J Oral Pathol Med. 2015 May;44(5):353-60. doi: 10.1111/jop.12296. Epub 2014 Dec 8.

PMID:
25482572
8.

The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.

Wang SJ, Peyrollier K, Bourguignon LY.

Arch Otolaryngol Head Neck Surg. 2007 Mar;133(3):281-8.

PMID:
17372087
10.

Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer.

Wang SJ, Bourguignon LY.

Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):19-24.

PMID:
16415424
11.

Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.

Chang KP, Wang CL, Kao HK, Liang Y, Liu SC, Huang LL, Hseuh C, Hsieh YJ, Chien KY, Chang YS, Yu JS, Chi LM.

Cancer. 2013 Nov 15;119(22):4003-11. doi: 10.1002/cncr.28300. Epub 2013 Aug 20.

12.

Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling.

Torre C, Wang SJ, Xia W, Bourguignon LY.

Arch Otolaryngol Head Neck Surg. 2010 May;136(5):493-501. doi: 10.1001/archoto.2010.25.

13.

ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma.

Grimm M, Krimmel M, Polligkeit J, Alexander D, Munz A, Kluba S, Keutel C, Hoffmann J, Reinert S, Hoefert S.

Eur J Cancer. 2012 Nov;48(17):3186-97. doi: 10.1016/j.ejca.2012.05.027. Epub 2012 Jul 10.

PMID:
22784549
14.

Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.

Twarock S, Freudenberger T, Poscher E, Dai G, Jannasch K, Dullin C, Alves F, Prenzel K, Knoefel WT, Stoecklein NH, Savani RC, Homey B, Fischer JW.

Mol Cancer. 2011 Mar 23;10:30. doi: 10.1186/1476-4598-10-30.

15.

Prognostic markers in stage I oral cavity squamous cell carcinoma.

Dunkel J, Vaittinen S, Grénman R, Kinnunen I, Irjala H.

Laryngoscope. 2013 Oct;123(10):2435-41. doi: 10.1002/lary.23888. Epub 2013 Aug 5.

PMID:
23918741
16.

Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.

Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H, Tanzawa H.

Int J Oncol. 2008 May;32(5):1001-9.

PMID:
18425326
17.

Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulation.

Chen CH, Chuang HC, Huang CC, Fang FM, Huang HY, Tsai HT, Su LJ, Shiu LY, Leu S, Chien CY.

Am J Pathol. 2013 Feb;182(2):516-28. doi: 10.1016/j.ajpath.2012.10.023. Epub 2012 Dec 3.

PMID:
23219753
18.
19.

Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma.

Kosunen A, Ropponen K, Kellokoski J, Pukkila M, Virtaniemi J, Valtonen H, Kumpulainen E, Johansson R, Tammi R, Tammi M, Nuutinen J, Kosma VM.

Oral Oncol. 2004 Mar;40(3):257-63.

PMID:
14747056
20.

Oropharyngeal malignant epithelial cell, lymphocyte and macrophage CD44 surface receptors for hyaluronate are expressed in sustained EBV infection: immunohistochemical data and EBV DNA tissue indices.

Groma V, Kazanceva A, Nora-Krukle Z, Murovska M.

Pathol Res Pract. 2012 Sep 15;208(9):518-26. doi: 10.1016/j.prp.2012.05.017. Epub 2012 Jul 6.

PMID:
22770970

Supplemental Content

Support Center